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CHAPTER I
THE PROBLEM ALL DEFINITIONS OF TERMS USED
In 1957, Nagao Nishimura made a rather startling 
proposition that linked collagen disease with hereditary
74 The postulated defect interferedmetabolic defects.
with the metabolism of phenylalanine and tyrosine re­
sulting in the excretion of a hypothetical abnormal
metabolite, 2,5-dihydroxyphenylpyruvic acid. To support 
his hypothesis he treated a series of 26 diffuse collagen 
patients by dietary restriction of phenylalanine and
75 The diet was typi-tyrosine with impressive results.
cally Japanese. A refined gelatin was used as the protein
source.
3The work of Centerwall and Acosta-^ published in
I960 included a diet with a controlled low intake of
phenylalanine for phenylketonuric infants. The protein 
source was Lofenalac, a low phenylalanine casein hydroly­
sate with added fats, carbohydrates and minerals, 
was therefore suggested that Lofenalac be used as the 
major protein source for a low phenylalanine and tyrosine
It
diet for adult collagen patients.
The object of this study was to observe the effects 
of dietary restriction of phenylalanine and tyrosine upon 
collagen disease as evidenced by changes in clinical 
progress, sedimentation rate and latex fixation tests.
2
It was desired to determine the effectiveness and prac­
ticability of the use of Lofenalac as the source of 
protein for adults on diets restricted in aromatic
amino acids.
The multiplicity of factors involved in the path­
ogenesis of collagen disease constitutes a medical jig
saw puzzle. The search continues for the key pieces
that will enable all the parts to fall into their proper
relation to each other.
The pessimistic prognosis and increasing incidence
30,57,96of the rarer collagen diseases and the prevalance
of disability from rheumatic fever and rheumatoid arth- 
78,82ritis lend urgency to investigations that give 
If Nishimurafs hypothesis shouldpromise of relief.
prove valid some of the puzzling paradoxes of collagen
disease would be elucidated.
The definition of the term "collagen disease" 
is elusive. Generally, disorders so designated 
have in common the following features: (1) un­
known etiology; (2) variable involvement of tissues 
of mesenchymal origin; (3) they are usually, al­
though not always, characterized by fibrinoid degen­
eration and frequently by hypergammaglobulinemia;
(4) poor prognosis; (5) diverse clinical manifes­
tations reflecting multiple system involvement;
(6) a favorable albeit often temporary response to 
steroid therapy; and (7infrequent 
pathologic similarities.-^0
Included usually in the classification of collagen
clinical and
disease are acute rheumatic fever, rheumatoid arthritis, 
systemic lupus erythematosus, scleroderma, polyarteritis
3
nodosa, thrombotic thrombocytopenic purpura, and derma-
tomyocitis. There is some lack of agreement as to which
diseases should be included in the classification.
CHAPTER II
REVIEW OF THE LITERATURE
Hernial Connective Tissue. Early in the 20th century
Schade called attention to the structure of connective
tissue and especially to the amorphous colloidal nature
of the ground or cement substance in which the cellular and
He called it the "con-fibrillary components are imbedded, 
nective tissue organ" and considered it to have important
62physiological functions.
The connective tissue system is the extracellular
framework or supporting system of the body. It is composed
of structural elements or fibers set in a nonstructural
61 ,63matrix or ground substance. The fibroblasts respon­
sible for the elaboration of fiber and matrix substances
are quite scattered and inactive in adult tissue but are
numerous in growing or healing connective tissue. Mast
cells that produce heparin and macrophages or wandering
cells are also present. Lymphoid cells of the connective
tissue are credited with the production of antibodies by
30some.
The fibers are of two kinds, collagenous and elastic.
Collagen represents approximately thirty per cent of the
total body protein. It is a fibrous protein occurring in
wavy, birefringent bundles of unbranched acidophilic fibrils
5
cemented together in a polysaccharide matrix. Collagen
forms gelatin if treated with boiling water and contains
large amounts of proline, hydroxyproline, glycine and very
The argyrophilicsmall amounts of aromatic amino acids.
reticulin or pre-collagen fibers also occur in wavy parallel
bundles but are arranged more haphazardly. They form a fine
and delicate supporting network for structures like the
spleen and vascular endothelium. They are smaller aggre­
gates of the same macromolecular fibrils that compose
26,41collagen fibers.
Elastic fibers are characteristically branched and
smooth and have a yellow color in contrast to the white
collagen. They are scarce except in certain areas such as
ligaments and arteries. They contain no hydroxyproline.
Degenerating elastic fibers reveal an affinity for calcium
and mucopolysaccharide.
The ground substance is formed of mucopolysaccharides, 
one group of which are chondromucoids. 49 These are highly
polymerized long chain compounds composed of glucuronic 
acid, galactosamine, sulfuric acid, and acetic acid loosely
combined with protein. Mucopolysaccharides are abundant in
the cementing substance where toughness is needed. They
also have an ion exchange function. Hyaluronic acid,
another type of polysaccharide, is similar except that it
contains no sulfuric acid and is found where lubrication
6
is the prime need as in the eye and joint spaces. The 
capacity of mucopolysaccharides to form either viscous 
lubricating fluids or stable tissue matrix depends upon 
flexibility in the degree of polymerization.
Support, continuity, integrity, and lubrication are 
provided by connective tissue. It also supplies the deli­
cate balance between barrier and transport function in the
41
movement of metabolites, water, electrolytes, and nutrients
(,The aggregate state ofbetween the blood and tissue cells.
hyaluronic acid and the nature of its bonds with protein
10determine intercellular exchange and barrier function."
Enzymes, enzyme inhibitors, vitamins, and hormones must be
present in intricate pattern for all these functions to
proceed normally.
Pathological Changes in Connective Tissue. The term
"fibrinoid degeneration”, frequently used to describe 
damaged connective tissue, arises from a similarity to 
fibrin of the necrotic collagen in its response to dyes.
However, this response is not consistent and there are
various changes in structure described as hyaline, granular
or fibrillary. There may also be seen degenerative, inflam­
matory and hypertrophic changes at the same time in very 
close proximity.
"The regular fiber pattern of normal connective
tissue is replaced by swollen, indistinct bundles or clumps
7
fr4l The intercellular ground sub-of amorphous material.
stance, scarcely visible in normal tissue, is more pro-
"There are three principlenounced in pathological tissues.
reactions of connective tissue to injury: fibrinoid 
necrosis, fibrillary augmentation leading to sclerosis, and 
cellular invasion and proliferation.” Cortisone inhibits
fibroplasia; desoxycortisone acetate and growth hormones
accelerate it. The spreading action or increased permeabil­
ity induced by hyaluronidase is inhibited by ACTH and 
indirectly by vitamin 0. 10 In the absence of vitamin 0
hydroxyproline is not formed therefore no new collagen is
laid down. With advancing age the collagenous component 
increases and the mucoid content decreases resulting in less 
elasticity of the tissues. The pathological changes in the
connective tissue of collagen diseases do not adequately
account for all of the profound systemic changes observed.
Autoimmunization. Death from anaphalactic shock 
due to sensitization by intracellular proteins released by 
massive injury is described as "crush syndrome." Death
from anaphalactic shock has been reported as occurring in
88,89collagen disease. The inclusion bodies of the typical
L.E. cell of systemic lupus erythematosus are demonstrated
to be nucleoprotein.^’^ Without question autoimmuni­
zation plays a prominent part in the pathology of collagen
disease. Is the cell damage with consequent release of
8
8D1TA protein a part of the sensitizing process or a result 
of some other factor? Does the depolymerization of nuclear 
proteins release tyrosine to accumulate or does defective 
tyrosine metabolism with associated conditioned ascorbic 
acid deficiency initiate the disorganization as suggested
23by Boscott?
Antimyosin antibodies have been observed in connec­
tion with injured muscle fiber. Could these be the result
of the same insult that causes the muscle weakness variously
manifested in collagen disease, or do they produce that
weakness?
Tyrosine and vitamin 0 are implicated in the activity
of the adrenals and the formation of epinephrine. Endocrine
influences upon allergic reactions are only partially under-
Cortisone and vitamin C are both involved in sensi-stood.
42 and both inhibit depolymeri-tivity and immune reactions
zation of the glycoproteins of the cementing ground
1 osubstance of connective tissues. Rise of serum glycopro­
teins due to depolymerization and/or failure to become
acute infections, rheumatic 
The rise in plasma glycoproteins
79polymerized occurs in scurvy,
58fever, and in cancer, 
which may be due to vitamin C deficiency is measured by
tyrosine content. The close correlation between alpha2 
globulin and mucoprotein tyrosine suggests that this frac­
tion of the plasma proteins may contain the serum mucopro- 
66,102tein.
9
The fibrinoid degeneration of connective tissue 
found in collagen disease is characterized by excessive 
ground substance with a high content of tyrosine-trypto-
Eheumatoid nodules are of 
The hematoxylin bodies, hyaline
phane containing protein.
2Qsimilar composition. ^ 
thrombi, L.E. cell inclusion bodies, and wire loop lesions 
common to systemic lupus erythematosus are also high in
548 says they appear toHolmantyrosine and tryptophane, 
be products of an abnormal immune system rather than res-
They are thought to be traceable toponsible pathogens, 
disrupted cell nuclei where such proteins in combination
This same typewith nucleic acid form the nucleoproteins.
of material is indicted in the type of immunization termed
1 ftskin graft immunity.
Metabolism of Phenylalanine and Tyrosine, 
animal body is unable to synthesize the benzene ring.60 
Phenylalanine and tyrosine are the chief sources of it
The
in food. The first step in the metabolism of phenyl­
alanine appears to be irreversible conversion to tyrosine. 
Por this reason phenylalanine can be used by the body in 
place of tyrosine but tyrosine cannot substitute for
phenylalanine. This reaction takes place in the liver of 
man, the enzyme requiring molecular oxygen and diphospho- 
nucleotide (DPH) or triphosphonucleotide (TPN). 




28amino group is lost to ketoglutarate by transamination 
yielding hydroxyphenylpyruvic acid and glutamic acid.
Vitamin C is necessary to the formation of 2,5-dihydroxy- 
phenylacetic (homogentisic) acid. How the arrangement of
the two hydroxyls takes place is not known.
The opening of the ring by the enzyme homogentisi-
case, a liver oxidase, results in the formation of fumaryl-
acetoacetic acid. This acid splits by hydrolysis into
fumaric and acetoacetic acids. Pumaric acid enters the
citric acid cycle while acetoacetic acid follows the
pQ
regular path of fat metabolism. Both phenylalanine
and tyrosine are completely utilized by the normal body.
4,28,These pathways are graphically presented in Figure 1. 
60,70,74,75,95,99
Phenylalanine is also partly oxidatively deaminized
to phenylpyruvic acid. Another hypothetical intermediate
is 2,5-hydroxyphenylpyruvic acid which yields homogentisic
acid by decarboxylation and oxidation. Some urinary
hippuric acid is thought to be of endogenous origin from
phenylalanine.
The production of certain pigments by another
metabolic pathway in which tyrosine takes part is of
interest. Tyrosine is oxidized to dihydroxyphenylalanine,
(or ”l)opa”) then to a red indole compound (5,6-dihydroxy- 
indole) by an oxidizing enzyme, tyrosinase. This is 
converted to melanin. Melanins are brown or black substances
11
of unknown composition found in skin, hair, the choroid
coat of the eye, and melanotic sarcomas. That their
formation is aided by light is demonstrated by the produc­
tion of freckles and tanning upon exposure of the skin to
4,19,60,70sunlight. See Figure 2.
Suggested pathways for the synthesis of epinephrine
and thyroxine from tyrosine are represented in Figures 3 
and 4. Norepinephrine is the primary adrenergic agent.
Triiodothyronine is five times as active as thyroxine and
is thought to be formed by deiodination of thyroxin. These
pathways are summarized in Figure 5.
Tyrosine is a reducing agent of considerable impor­
tance and derives this property from its hydroxyl group.
Requirements for Phenylalanine and Tyrosine. Rose 
and collaborators tentatively proposed a minimum require­
ment for phenylalanine of 1.1 gm. and a safe intake of
522.2 gm. per day for the adult human male. This proposal
was the result of six quantitative experiments in which a 
range of 0.8 to 1.1 gm. were required daily to maintain
4nitrogen equilibrium. According to Albanese, male infants 
require 169 mg. phenylalanine per kilogram per day, a higher 
requirement than that of the adult. Leverton reports a
minimum daily requirement of 220 mg. phenylalanine in the
106presence of 900 mg. tyrosine for college women.
The requirement may be partially but not completely
This sparing action of tyrosine mayreplaced by tyrosine.
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SUMMARY OF METABOLIC SCHEMES
16
cover 70 to 75 per cent of the phenylalanine requirement.
Human cells in tissue culture are not able to convert
phenylalanine to tyrosine efficiently enough to permit 
growth. 107
D-phenylalanine is utilized but cannot completely
replace the L-isomer.
Symptoms of phenylalanine deficiency are negative 
nitrogen balance, cessation of growth, inanition, reduced 
hemoglobin and plasma protein — the nonspecific evidences
of protein malnutrition.
Since practically all food proteins contain about
5 per cent of phenylalanine by weight there is no possi­
bility of a dietary deficiency if the protein intake is 
adequate. ^>70
Protein Metabolism. Nitrogen balance in the adult
organism can be established at various levels of protein
intake. How much longer the scientific controversy will
wage over which level is optimum will depend upon the
development of adequate critera for correct evaluation.
Increased strength and vigor on the basis of subjective
evaluation has been claimed both by advocates of low pro­
tein regimes and by proponents of high protein intakes.59 
The high levels of protein intake that produce'maximum
growth in the young animal are not necessarily optimum 
for health and longevity. 75,76,85,104,105 Neither can it
be said that balance at the lowest possible level could be
17
107optimum for vigor and disease resistance.
91Scrimshaw, Guzman, and de la Vega were puzzled by
the observation that central American children on protein
intakes marginal in amount revealed higher serum albumin
levels than children in the United States with much more
liberal intakes. Such observations are reassuring to
research in which low protein diets are used without alter­
native.
Hereditary Metabolic Disease. The study of inherited
abnormalities of metabolism has contributed much to the know-
4,20,70,65ledge of the metabolism of phenylalanine and tyrosine.
These diseases (albinism, alcaptonuria, phenylketonuria) are
the result of biochemical errors or metabolic blocks in the
intermediary pathways of phenylalanine and tyrosine metabolism 
graphically illustrated in Figure 1. The symptoms may be 
varied and far removed from the site of the underlying abnor­
mality. Indirect consequences of the absence of normal
products or of the accumulation of abnormal metabolites are
the subjects of much investiga.tion.
Uishimura’s^ hypothetical block which postulates
17,19,43,65,95
that 2,5-dihydroxyphenylpyruvic acid is an abnormal metabo­
lite classifies collagen diseases as heriditary metabolic
disorders. It has been reported that a group in France have
95supported his findings. Whether the obvious abnormal metabo­
lism of aromatic amino acids in collagen disease is a primary
defect or a secondary effect awaits elucidation.
18
Interrelationships. The place of pyridoxine in the 
metabolism of phenylalanine and tyrosine has been pointed 
out. Thiamine, as cocarboxylase, may also be essential to 
the decarboxylation of all keto acids, 
with guinea pig slices revealed a failure of scorbutic 
tissue to oxidize the side chain of tyrosine. Polacin
97 In vitro studies
prevented the hydroxyphenyluria from tyrosine feeding of
scorbutic guinea pigs but did not prevent scurvy. This 
work was not verified in monkeys or infants. An enzyme 
from rabbit liver has been shown to convert para-hydroxy-
phenylpyruvic acid to 2,5-dihydroxyphenylpyruvic acid in
the presence of vitamins C and B Homogentisicase, the12-
liver oxidase which cleaves the ring is greatly reduced in
livers from scorbutic animals. The activity can be restored
either by vitamin 0 or by ferrous ions which are required
for enzymatic oxidation of homogentisic acid. It is there­
fore concluded that vitamin C has a nonspecific effect as a
23,27reducing agent maintaining iron in the ferrous state.
The sulfur-containing amino acids, such as methionine,
contribute methyl groups for the transformation of tyrosine
to epinephrine. Tyrosine is found in normal human urine as
the ortho-sulfate derivative and apparently occurs in this
form in fibrinogen. Ascorbic acid oxidation-reduction
reactions involve SH groups such as are supplied by gluta­
thione. 71
The abnormal pigmentation characteristic of Addison1s
19
disease is evidence of some relation of the adrenal gland 
to the metabolic pathway from tyrosine to melanin. Abnormal
pigmentation occurs also in scurvy, scleroderma, lupus erythe­
matosus, and certain hereditary metabolic diseases.
Tyrosine transaminase and dihydroxyphenylalanine
decarboxylase require pyridoxine as a coenzyme.




Since tyrosine is oxidized by transamination with
alpha-ketoglutaric acid which is a product of the citric
acid cycle, anything that interferes with normal energy 
metabolism can hamper tyrosine metabolism. Pyridoxine, 
niacin, thiamine, riboflavin, and pantothenic acid are all
essential in the citric acid cycle.
There is a close relationship between the metabolism
17,71of phenylalanine and tyrosine and that of tryptophane. 
98,109
33Collagen Disease. Dubois, working at the Los
Angeles County Hospital, has accumulated a sizeable series
He calls it "the overlooked diagnosis"of collagen cases.
and directs attention to the great variety of symptoms
that may be presented. These are truly multiple system
34 an incidence of lupus erythema­
tosus greater than that of leukemia, Hodgkin’s disease 
and pernicious anemia and one half that of rheumatic
diseases. He reports
36 Much collagen disease is masquerading underfever.
some other diagnosis. It seems to be steadily on the
20
increase. Kampmeir-^ suggests as possible causes for the 
increased incidence, the almost universal exposure to drugs
during the past twenty-five years and "for the first time an 
inordinate exposure of the lightly pigmented Caucasian shin 
to sunlight in the pursuit of ’sun worship’." Drugs may act
as sensitizers and sunlight may stimulate autoimmunization.
It is well known that exposure to sunlight may precipitate 
serious consequences in collagen disease.57,88
There is such a close interrelationship between the
various collagen diseases that differential diagnosis is
Often one will in time progress 
13,24,44,49,57,66,73,80,
difficult if not impossible.
into or be superimposed upon another. 
84,93 Thus what appears to be a typical rheumatoid arthritis 
turns out to be a case of lupus or scleroderma. Lupus is
often mistaken for rheumatic fever or polyarteritis and at
times has been confused with the other members of the group.
Polyarteritis has been mistaken for or associated with rheu­
matic fever. Some contend that scleroderma and dermatomyo- 
sitis are really the same disease. "This strong clinical
overlapping as well as the presence of a similar pathology
may possibly suggest that diseases of collagen are but various
stages or fractions of the spectrum of one and the same dis-
26,576333ease." Dubois Klemperer and Baehr contend that each
is a distinct disease entity and never overlap or progress
from one to the other.
Some type of pulmonary involvement is almost certain
21
11to occur at some time during the course of a collagen disease.
It is sometimes difficult to tell if this is an integral part
of the disease or a complication. The pulmonary symptoms
are of a wide variety and non-specific in character.
The collagen diseases as a group have been considered
recurrent and incurable with a poor prognosis. Treatment
has been supportive and symptomatic. Steroid therapy has
35been more successful than anything yet tried. It often
produces spectacular results and usually affords at least a
25,51,59,67,72,86,92degree of relief.
The side effects of corticosteroid therapy such as 
increased appetite, hirsutism, moon facies, and other symp­
toms of Cushing's syndrome must be carefully watched. Stimu­
lation of the gastrointestinal tract producing peptic ulcers
and multiple hemorrhages of the intestinal mucosa is a serious
effect especially since such conditions may be produced by
Severe muscle weakness and atrophy, 
striae, and ecchymoses are other symptoms that might indicate
the disease itself.
an accentuation of existing symptoms particularly of dermato-
myocitis and purpura. Disturbances of water and mineral
balance are also factors to be seriously considered in a
group of diseases in which heart and kidney involvement are
to be expected.
Diet modification during steroid therapy is common.
There may be routine sodium restriction, potassium supple­
mentation, and prophylactic ulcer diet. However some steroids
22
do not require sodium restriction. Occasionally calorie
restriction is required to control weight in long term steroid
therapy.
High protein, high vitamin and mineral diets are
usually recommended. High calorie diets have been considered
necessary to combat the emaciation and wasting. If there is 
dysphagia it may be necessary to try to meet the nutritional 
needs of the patient with nourishing liquids. Diets must 
be modified to meet the various crises through which the
patient passes depending upon the specific organs affected. 
There is a current report of excellent results obtained in
the treatment of rheumatic fever with B factors^ a.nd heavy
108doses of vitamin C. This has not been substantiated.
Rheumatoid Arthritis Like rheumatic fiver rheuma­
toid arthritis is characterized by disseminated arteritis, 
pancarditis, polyarthritis, and subcutaneous nodules containing 
gamma globulin and deposits rich in tyrosine and tryptophane. 
However unlike rheumatic fever it is accompanied by crippling 
arthritis involving both joints and muscles, 
times as frequent in females as in males, is prevalent in
It is three
the temperate zone and rare in the tropics, and is essentially 
a disease of young people, the average age at onset being
Op
thirty-five years. The etiology in common with other col­
lagen diseases is unknown, 
listed as shock,^
Precipitating factors may be 
prolonged fatigue, trauma, infections, 
exposure, constitutional inferiority and heredity. Treatment
23
includes physical therapy, 78 salicylates, removal of foci of 
infection, gold therapy and steroids. There is some evidence 
that steroid therapy may lead to the development of polyar­
teritis nodosa in patients with rheumatoid arthritis.
The various diets suggested in the past have "been 
largely rejected.^2 Low calorie diets may markedly interfere
with optimum nutrition for many of these patients are mal­
nourished and anorexic. Since the decreased carbohydrate
tolerance observed in this disease is probably caused by
the chronic inflammatory state rather than defective sugar 
metabolism the low carbohydrate diet has also been rejected. 
The benefits attributed to these diets were probably due to 
the increased intake of minerals, vitamins and protein by 
the elimination of f,empty calorie" foods. Massive doses of 
vitamin 1 are now considered dangerous. Excess dosage of 
other vitamins and minerals have not proved beneficial.
The victim of rheumatoid arthritis has a systemic disease
and is a sick individual. He has a negative nitrogen and
calcium balance with muscle atrophy and decalcification of
The progressive, inflammatory tissue disorder goes 
on for years. Good nutrition is of fundamental importance. 
Bayles26 suggests about 150 gsi. carbohydrate, 80 - 100 gm. 
protein, and 80 - 100 gm. fat depending on the patient*s
bone.
relation to normal weight. Fresh fruits and vegetables should
be emphasized.
Scleroderma. Scleroderma is characterized by diffuse
24
induration and immobility of the skin with pigmentation,
sclerodactylia and arthritis. The face and hands are usually 
involved. Beginning symptoms are suggestive of Reynaud‘s
disease.
The cutaneous changes pass through several stages, 
the first of which is a brawny edema. Then the skin 
becomes smooth, waxy, hard and tight so that it cannot 
be lifted from the deeper structures. As the disease 
advances to the atrophic stage, the skin becomes 
thinner, smoother and completely adherent to the 
shrunken muscles. The movement of joints is progres­
sively restricted until the patient resembles a living 
mummy.2^
A mask like face is characteristic. Frequently there
is brownish pigmentation of the skin, also depigmentation
in severely affected areas. Calcium deposits may form in
the diseased portion. Calcium sludge may extrude from the
ends of the fingers. loss of hair, coldness of the digits
and painful ulcers may occur. The esophagus frequently
becomes enlarged and stiffened with resulting dysphagia.
Peculiar fibrosis of the heart, lungs and kidneys are serious
complications. Death may follow in a few months in acute
cases but usually the process requires years for full devel- 
In 1868 Addison described the affected part 
as becoming "hide-bound" to such an extent that "the whole 
of a limb, but especially the fingers may be permanently 
contracted, bent, and rendered almost as hard and immovable 
as a piece of wood; thereby impeding progression, distorting
26,96opment.
the gait, and making the patient a poor miserable cripple
u96for the remainder of his life.
25
Treatment is entirely symptomatic and supportive 
consisting of warm baths, massage, heat, softening ointments, 
high calorie, high vitamin diet, and removal of foci of in­
fection* Short steroid courses are used but may give rise
to malignant hypertension or arteritis nodosa. Sympathectomy
96has been used.
CHAPTER III
RESCRIPTIOH OP METHODS USED
Patients for this study were 
selected on the bases of (1) severity of clinical symptoms, 
(2) psychological ability to cooperate, (3) positive latex
fixation, and (4) elevated sedimentation rate.
The test diet was set up to contain no
Selection of Patients.
Test Diet.
more than 1500 mg. daily of phenylalanine and tyrosine 
combined. This was achieved by the use of Lofenalac (see 
Appendix for composition) as the major source of protein.
One cup (144 gm.) of Lofenalac furnished 24 gm. of protein 
and 120 mg. each of phenylalanine and tyrosine. Low protein 
foods# were selected to bring the total daily protein to 
36 gm. and the phenylalanine and tyrosine to not more than 
1500 mg. In most cases, inbetween meal nourishments of 
vegetable consomme were served to increase the supply of 
minerals and vitamins with little increase in protein. A 
vitamin supplement (see Appendix) was given during the entire
test period.
Patients were asked to keep some pure sugar candy 
at hand to use only if a meal seemed particularly unsatis- 
Small amounts of Seven-up were also permitted.fying.
Tobacco, tea, coffee, and alcohol were not to be used during
Any portion of meals not eaten wasthe period of study.
# See Appendix.
27
to be returned to the kitchen to be weighed.
Since the patients were to remain on the test diet
following the 10-day hospitalization period they were given
thorough diet instructions during the time they were hospital­
ized. Sample exchange lists, hospital menus and home instruc­
tions are included in the appendix.
Medications. All previous medications were discontin-
Ten grains of aspirin were to be given every four hoursued.
for pain, if needed. Nembutal, one and one-half grains, was
to be given as necessary for sleep.
Time Involved. Dietary restriction of phenylalanine
and tyrosine was prescribed for seven patients with collagen 
disease for a period of six weeks. Hospitalization was re­
quired for the first ten days. The diet was continued under
home supervision for the remainder of the experimental period.
Laboratory Tests. Samples of blood and 24-hour urine 
specimens from each patient were submitted for laboratory 
analysis at the time of admission to the hospital. The 
analyses were repeated at weekly intervals for a period of
six weeks.
Blood determinations included glucose, hemoglobin, 
hematocrit, sedimentation rate, total protein, albumin, 
globulin, albumin-globulin ratio, thymol turbidity, and 
rheumatoid arthritis (R.A.) latex globulin test, 
hospital routine tests also are reported. Serum samples
38 Other
were frozen for tyrosine determinations.
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Urine determinations included, in addition to hospital
routine, creatinine and urea nitrogen.
The reagents for the rheumatoid arthritis latex globulin 
test were obtained from the Hyaland laboratories and the thy­
mol turbidity liver function measurements from Shank and
Hoagland. The liver function tests were uniformly normal
and were discontinued after a few weeks. The total serum
protein for the albumin-globulin ratio was by the Kingsley-
Biuret method. The urine creatinine was determined by the
standard picrate procedure. Urea nitrogen was determined by
a microphenate-hypochlorite method developed by the Chaney
The total 24-hourlaboratories and distributed by Hyaland. 
nitrogen values for the nitrogen-creatinine ratio81 was
approximated by increasing the sum of the urea and creatinine
nitrogen by five per cent. These determinations are as yet 
incomplete.
The frozen serum specimens for the beginning and the 
end of the experimental period for cases 1 and 2 have been
sent to the Chaney laboratories for tyrosine determination.
These are not yet completed.
CHAPTER. IV
STATEMENT OE RESULTS OBTAINED
The accompanying graphs, Figures 6 to 12, plot the
changes in hematocrit, sedimentation rate, albumin globulin 
ratio and latex fixation tests in all patients.
It is of interest to note that these six patients 
(excluding case number 5), on a marginal intake of not more 
than 36 grams of protein daily and about 1500 calories (more 
for one of the men) for six weeks showed an average decline 
in hematocrit of only 1.1. One showed a slight rise, two 
remained quite constant, and one shows unreasonable variation. 
Case number 4, who dropped out because of vomiting, was not 
included in the average. Her reports were included because
there was a drop in both A.G. ratio and R.A. latex fixation
during her stay in the hospital. When she went home, the 
R.A. fixation rose again which was of interest because it
was obvious that she was not cooperating. The scale for
the R.A. latex fixation was set up arbitrarily to express 
the degree of agglutination. There was no drop in serum
albumin. Body weights were held constant and there was no
evidence of deterioration of nutritional state.
The following case reports summarize the individual
results:
Case number K A 48-year-old white man was admitted 
as a research patient March 10, 1961. He had been unable 
to work for three months due to an arthritic knee ;}oint
30
and could not walk without crutches or bend the inflamed 
knee. The latex fixation test was definitely positive 
but not strongly so. Synovial fluid removed from the 
knee showed poor mucin precipitate with shreds and cloudy 
solution.
On the day following admission, his diet was reduced 
from 2000 calories to 1500 because "it was too much" 
for him. He preferred his Lofenalac unflavored. He 
was easy to please and very cooperative with those res­
ponsible for working out the details of a new and rather 
difficult dietary regime. On the third day there was 
some improvement, on the fifth day he could bend his 
knee better than 100° without pain. When he left the 
hospital after ten days the knee has stiffened and 
could flex only to about 40° but there was no pain.
He walked out without crutches and went to work the 
next day. He lost three days work after spraining his 
ankle April 5. This injury was followed by much pain 
and swelling which was discouraging to him. He complain­
ed of persistent halitosis which he attributed to the 
Lofenalac. He has continued to improve with ups and 
downs. He was anxious for a beefsteak the Sunday 
following the end of the experimental period but re­
ports that he still stays on his diet "most of the 
time" and feels well rewarded for his effort. The fact 
that he is a strict Catholic and was admitted during 
Lent may have influenced his beginning laboratory find­
ings.
Case number 2. A 42-year-old white woman was admitted 
March 15’ 19&1. Her illness began four years before with 
pain and swelling of the left shoulder so severe as to 
require hospitalization and injections. Six months later 
both shoulders, knees, and feet were involved. She spent 
three weeks in the Pinehurst Clinic, wheeler, Oregon.
Except for waning of acute flare-ups she felt she had 
made no improvement but had been gradually getting worse. 
She has been taking cortisone for a year and has required 
15 to 20 aspirins daily. Her hands and wrists were swollen 
and painful. She could not comb her own hair and brushed 
her teeth with great difficulty in a contorted position.
She could get down steps by going backwards with support. 
She would be more helpless if she were not so spirited 
and courageous. During her first few days in the hospital 
she had headaches, probably due to a lack of coffee. She 
improved slowly but steadily without cortisone and with 
aspirin only occasionally. She followed her program 
faithfully after leaving the hospital. She went home to 
Idaho happy to be able to comb her hair, brush her teeth 
and hold a gun for target practice with her husband. The 
physiotherapist who had treated her previously was impress­
ed with the improvement in her joints. She wishes to
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continue her diet.
Case number A 59-year-old white male with degen­
erative arthritic joint changes of ten years duration 
was admitted March 20, 1961. A number of conspicuous 
rheumatoid nodules made this patient of interest for 
this study. One nodule was removed for a pathology 
report. He was over six feet tall and began to lose 
weight on the diet. His calories were increased to 
2500 and again to 3000 when he went home to work. On 
this intake he neither gained nor lost weight. This 
man had a well controlled colostomy which became some­
what of a problem on this diet. His improvement was 
definite but not at all spectacular. There was no 
change in the nodules. However he came into the doctors 
office on May 11 feeling much improved and very happy 
about it. His knees and wrists were much less painful.
Case number 4. A 40-year-old white female was ad­
mitted March 17, 1961 with stiff, swollen, and painful 
right shoulder, elbow, knee, ankle and both feet. Present 
illness began 14 months before. On the third and fourth 
days she was considerably improved but was not encouraged 
to try to continue because she did not appear to be suf­
ficiently stable emotionally to be depended upon. She 
decided to stay but was unable to abstain from tobacco 
and alcohol. She had vomiting spells on March 22 and 27 
and after she went home. Her last report was March 26. 
This case is reported only because of the possible sig­
nificance in her laboratory reports.
There is a possibility that the vomiting could have 
been caused by rapid absorption of free amino acids as 
suggested by Wohl and Coodhart.10^ It would have been 
advisable to try smaller, more frequent feedings of 
the protein digest.
Case number ^>. A 45-year-old Mexican woman with 
multiple, painful joint involvement was admitted March 
21, 1961. Ho noticeable improvement was observed during 
the experimental period.
Case number 6. A 61-year-old Mexican woman with 
multiple joint involvement and especially pain in the 
neck, shoulders and hands was admitted April 6, 1961.
She complained constantly of pain in spite of medication 
and improved very little. Pood was reported smuggled in 
to her.
A 65-year-old Mexican woman with
Present ill- 
She is almost
Case number £. 
scleroderma was admitted March 24, 1961. 
ness is of two years known duration.
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totally deaf, but very cooperative. The greatest prob­
lem was dysphagia. After a few days her intake became 
totally inadequate so her days allotment was prepared 
in the form of eight liquid feedings given at intervals 
of one and one half hours. This was tolerated quite 
well. After five or six days she received solid food 
again at her request. The stiffness and pain in her 
fingers and forearms have improved. There is increased 
mobility of fingers and jaw. She is particularly pleased 
to be able to "open her mouth” and is very grateful for 
the improvement in dysphagia and esophagitis which she 
terms "heart burn". She is continuing with supervision 
on the diet but often does not eat as much as is pre­
scribed.
Arthritis cases 1 and 2 were greatly benefited.
3 was only moderately benefited unless the delayed improve-
Case 4 was unsatisfactory. 
Cases 5 and 6 were benefited very little if any.
Case
ment is attributed to the diet.
The sclero­
derma case seems to present remarkable improvement considering 
the absence of previous remissions.
Neither of the two cases of rheumatoid arthritis
who responded well had strongly positive S.A. tests. The
two who did not respond at all had very strongly positive
R.A. tests which remained so throughout the experimental
period. The sedimentation rate paralleled clinical progress
to some extent at least.
CHAPTER V
DISCUSSION
If, when this series of patients is enlarged, clinical 
improvement is significant; the same regime, except for the
substitution of soylac or a similar product, should be under­
taken in order to determine if the benefit is derived from
curtailment of aromatic amino acids or from lowered protein
intake of some other unavoidable concomitant modifications
of the diet. Improvement, if due to restriction of phenyl­
alanine and tyrosine, could be considered evidence in support 
of Nishimura's hypothesis; however, there are other possi­
bilities to be considered. It is conceivable that the
organism, overloaded with the abnormal catabolism of aro­
matic amino acids evidenced in certain collagen diseases,
would be benefited by their restriction. There is also the
possibility that the formation of immune bodies could be
curtailed by such restriction or that the relation of
tyrosine to hormone production could affect endocrine balance.
If aromatic restriction benefits by way of inhibiting 
sensitization, the effect of such restriction upon skin 
graft immunity might be worth investigation. Even though
skin graft immunity is species specific and the sensitizing
material of certain collagen diseases is not; the antigen 
in both instances is nucleoprotein or desoxyribonucleic
acid.
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The relation of light sensitive dermatoses common in 
collagen disease to tyrosine as a ffsun trap”^ or to melanin 
as an ultraviolet screen raises further questions as to
possible means of interruption of disease processes.
There is the possibility that a drastic change in the 
diet may force a readjustment of a disordered metabolism.
If the new regime offers the essential nutrients there could 
possibly be therapeutic benefit in the demand for physiolo­
gical adjustment to an entirely new order of things, 
is also the alternate possibility of traums to the organism
There
from sudden change.
Benefit could be attributed to the abandonment of
unhygienic habits and unwholesome foods, or to increased 
consumption of foods high in vitamins and minerals.
In order to accomplish the reduction of aromatic amino 
acids in the diet, the protein allowance was lowered to a 
marginal level. Without question there are times when a
negative nitrogen balance renders high protein intake a
life saving emergency measure. Perhaps there is a need to
explore the idea that pathology produced by or associated
with excessive protein catabolism might be reversed by 
lightening the load. The curtailment of grains and grain 
products and natural protein foods poses the problem of 
nutritional adequacy and raises the question as to which 
of the many modifications of the diet should the results,
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If the effort to make theif significant, be attributed.
diets as nutritionally abundant as possible in face of such
restrictions resulted in improvement of some dietaries, the
failure to do so would have resulted in worsening of others.
Such a failure could also render ineffectual measures
that might have proved beneficial if all other links in the
metabolic chain were intact.
The Lofenalac was accepted better than anticipated.
Most of the patients found it easier to take if flavored
The pudding recipes developed by Acosta-^with molasses.
were a very useful means of incorporating part of the
necessary Lofenalac. Danish dessert was also useful for
this purpose. Since the thickening agent in Danish dessert 
is sta.rch the protein content approximates that of the
pudding recipes. For patients who did not care for pudding
the two tablespoons of Lofenalac were blended with four
ounces of pineapple juice.
The exchange lists devised by Acosta^ were intended 
for the use of infants and small children. The biscuits
were not very useful for most adults. One tall man laugh­
ingly complained that he lost his biscuits under his honey.
More patient satisfaction was derived from the use of the
bread exchange for cereal in the morning, and potato or
corn at the other meals. Soda crackers for soup were
appreciated. Two Mexican patients were touchingly grateful 
when it was decided to allow a small portion of corn tortilla
36
for the bread exchange. On Easter the recipes for cookies
and ice cream were used, but in general it was felt that if 
the exchanges were filled largely by fruits and vegetables 
the diets would be more nearly adequate.
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CHAPTER VI
CONCLUSION
A progress report of a pilot study In which six
rheumatoid arthritis patients and one scleroderma case were
treated with a diet low in phenylalanine and tyrosine is
presented.
The diets supplied approximately 1500 calories and
36 grams of protein. Lofenalac, a casein hydrolysate,
was the principle source of protein. The diets were quite
well received, and there were no evidences of inadequate
nutrition. The scleroderma patient and three of the
arthritic patients improved. One case was unsatisfactory
and two did not improve. The sedimentation rates roughly 
paralleled clinical progress. The reports of other labora­
tory analyses that have been completed so far do not appear
to be significant.
It is recommended:
That the effect of dietary restriction1.
of aromatic amino acids be observed upon a larger series 
of patients with collagen disease.
That control periods be included in the2.
experimental plan in which Soyalac or a similar product
shall be substituted for Lofenalac in the diet.
The implications of the confirmation of Nishimura‘s
hypothesis have been discussed.
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Approximate Analysis of Lofenalac^
Standard dilution 
(1 meas. in 2 oz. 
water)
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POOD PATTERN FOR ONE DAY
Protein 36 gramsCalories 1500











































VEGETABLE EXCHANGE 15 mg. PA
3 TAsparagus, cooked 25 gm. 
24 gm.3 TBeans, green, cooked
6 TBeets, canned 50 gm.
2 small budsBroccoli, cooked 15 gm.
4 T shreddedCabbage, raw 30 gm.
2 small pieces 
l/3 large
1 1/2 small stalks 
1 small
Cauliflour 20 gm.
Carrots, raw 30 gm.
Celery, raw 25 gm.
Cucumber 100 gm.
Eggplant 35 gm. 
24 gm.4 T shreddedLettuce
6 TOnions 50 gm.
3 TOkra 25 gm.
Spinach or other greens, cooked l/2c = 3 exchanges 20 gm.
4 TSquash, summer, cooked 50 gm.
2 TSquash, winter, cooked 25 gm.
1/4 smallTomato, raw 25 gm.
2 TTomato, canned 25 gm.
2 1/2 T 
1/3 C




FRUIT EXCHANGE 15 mg. PA












3 T (scant) 1/6 c 




Apple juice 300 gm.
Apricots, canned 50 gm.
Apricot juice 60 gm.
24Banana gm.
Berries, canned, boysen 50 gm.
14Dates gm.
Fruit Cocktail 75 gm.
Grapefruit juice 60 gm.





Grape juice 90 gm.
Lemon juice 453 T gm.
1 l/2 halves 
1/3 medium 
3 halves
1 1/2 small slices 
1/3 cup 
1/2 cup 
1 l/2 medium 
1/2 cup (scant)
Peaches, canned 66 gm.
Pears, raw 40 gm.
Pears, canned 150 gm.
Pineapple, canned 75 gm.
Pineapple, raw 75 gm.
Pineapple, juice 100 gm.
Plums, canned 75 gm.
100Plums with tapioca gm.
40 gm.2 mediumPrunes
61
6 T (3/8 oup) 
















BREAD EXCHANGE 30 mg. PA
1 small by recipe 














30 gm.3 TPotato, sweet
2 1/2 T
l/2 cup = 3 exchanges 25 gm.
31 gm.Potato, Irish
Rice






























































Perrons Sulfate, dried 
Potassium Iodide USP 
Copper Sulfate 
Magnesium Sulfate dried 
Potassium Sulfate 
(from Dicalcium Phosphate) 
(Anhydrous


















74-7 mg. ) 22
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Nishimura7^ made a startling proposition that linkedIn 1957,
collagen disease with hereditary metabolic defects. This defect
was stated to be in the metabolism of tyrosine. Based on this report,
a pilot study was conducted in which six rheumatoid arthritis patients
and one scleroderma case were treated with a low phenylalanine and
tyrosine diet.
The diets supplied approximately 1500 calories and 36 grams of
No more than 1500 mg. combined phenylalanine and tyrosineprotein.
were given in any one day. Lofenalac was used as the principle source
of protein.
During the six week' test period laboratory studies were carried
out at weekly intervals for determining the following: blood glucose,
hemoglobin, total protein, albumin, globulin, A.G. ratio, thymol-
turbidity, rheumatoid arthritis latex globulin test, hematocrit, and
Clinical progress was also noted in each individ-sedimentation rate.
ual.
The diets were quite well received and there were no evidences
of inadequate nutrition. The scleroderma patient and three of the
arthritic patients improved. One case showed unsatisfactory improve-
The sedimentation rates roughlyment, while two showed no improvement.
paralleled clinical progress. The reports of completed laboratory
analyses did not appear significant.
It was concluded that bafeeii *011'-results“obtaineci,'. investigation
should be continued before significant‘■fftatemenis could be made.
ii
